These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 29239664)

  • 1. Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study.
    Reed K; Collaku A; Moreira S
    Curr Med Res Opin; 2018 Apr; 34(4):689-699. PubMed ID: 29239664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis.
    Prior MJ; Harrison DD; Frustaci ME
    Curr Med Res Opin; 2014 Nov; 30(11):2377-87. PubMed ID: 25121804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.
    Peloso PM; Bellamy N; Bensen W; Thomson GT; Harsanyi Z; Babul N; Darke AC
    J Rheumatol; 2000 Mar; 27(3):764-71. PubMed ID: 10743822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.
    Gibofsky A; Hochberg MC; Jaros MJ; Young CL
    Curr Med Res Opin; 2014 Sep; 30(9):1883-93. PubMed ID: 25050589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
    DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
    Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Gana TJ; Pascual ML; Fleming RR; Schein JR; Janagap CC; Xiang J; Vorsanger GJ;
    Curr Med Res Opin; 2006 Jul; 22(7):1391-401. PubMed ID: 16834838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
    Kulkarni MP; Shakeel A; Shinde BS; Rosenbloom RA
    Am J Ther; 2011; 18(2):170-7. PubMed ID: 21317618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee.
    Stebbings S; Gray A; Schneiders AG; Sansom A
    BMC Complement Altern Med; 2017 Aug; 17(1):416. PubMed ID: 28830491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
    Altman R; Hochberg M; Gibofsky A; Jaros M; Young C
    Curr Med Res Opin; 2015 Dec; 31(12):2331-43. PubMed ID: 26503347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomised comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of the knee or hip.
    Boureau F; Schneid H; Zeghari N; Wall R; Bourgeois P
    Ann Rheum Dis; 2004 Sep; 63(9):1028-34. PubMed ID: 15308513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
    Leung AT; Malmstrom K; Gallacher AE; Sarembock B; Poor G; Beaulieu A; Castro R; Sanchez M; Detora LM; Ng J
    Curr Med Res Opin; 2002; 18(2):49-58. PubMed ID: 12017209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic efficacy of sustained release paracetamol in patients with osteoarthritis of the knee.
    Bacon TH; Hole JG; North M; Burnett I
    Br J Clin Pharmacol; 2002 Jun; 53(6):629-36. PubMed ID: 12047487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.
    Pincus T; Koch G; Lei H; Mangal B; Sokka T; Moskowitz R; Wolfe F; Gibofsky A; Simon L; Zlotnick S; Fort JG
    Ann Rheum Dis; 2004 Aug; 63(8):931-9. PubMed ID: 15082468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial.
    Batlle-Gualda E; Román Ivorra J; Martín-Mola E; Carbonell Abelló J; Linares Ferrando LF; Tornero Molina J; Raber Béjar A; Fortea Busquets J
    Osteoarthritis Cartilage; 2007 Aug; 15(8):900-8. PubMed ID: 17387026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.